Category: Press Releases

New biomarkers for bowel cancer treatment

New biomarkers for bowel cancer treatment Scientists can predict in the lab whether a drug will be effective for individual colorectal tumors Colorectal carcinomas arise in different forms, so all treatments do not work for all patients. OncoTrack, a public-private consortium supported by the Innovative Medicines Initiative Joint Undertaking, has conducted one of Europe’s largest […]

Read More

Alacris receives DIN EN ISO9001:2015 certification

The quality management of Alacris Theranostics GmbH has been certified by TÜV Süd according to ISO 9001:2015. Alacris therefore fulfills the requirements for a quality management system according to the latest revision of ISO 9001. Alacris focuses on personalized medicine and requires its own state-of-the-art next-generation sequencing lab with an efficient sequencing and data analysis […]

Read More

Basis for new treatment options for a fatal leukemia in children revealed

Detailed molecular analyses allow new insights into the function of tumour cells and options for new treatments Berlin, 29th July 2015 – Acute lymphoblastic leukemia (ALL) leukemia is the most common type of cancer in children. It can occur in various forms, differing not only by specific changes in the genetic material of the leukemia […]

Read More

Alacris wins the Deutsche Innovationspreis 2015

The Deutsche Innovationspreis 2015 was awarded in Munich on Friday, April 24th. Alacris is the proud winner in the category Small and Medium Sized Enterprises. Our innovation ModCellTM convinced the jury. They agree with us that our systems biology approach not only helps physicians and clinics to find the right drug for the right patient. […]

Read More

European consortium to validate blood-based biomarkers for cancer

Alacris is one of the partners of CANCER-ID, a newly formed European consortium funded by the Innovative Medicines Initiative (IMI). CANCER-ID consists of currently 33 partners from 13 countries aiming at the establishment of standard protocols for and clinical validation of blood-based biomarkers. The consortium brings together experts from academic and clinical research, innovative Small-to-Medium […]

Read More

InnoLife-consortium winning bid of Healthy Living and Active Ageing of the European Institute of Innovation and Technology (EIT)

InnoLife, a consortium of 144 European companies, research institutes and universities, has been selected by the European Institute of Innovation and Technology (EIT) as the Knowledge and Innovation Community (KIC) for EIT Health. With a total volume of EUR 2.1 billion it is one of the largest public funded initiatives for health worldwide. EIT Healthpartners, […]

Read More

Alacris Theranostics: ModCellTM system will use the SAP HANA® platform

Berlin, 1st April 2014 – Alacris Theranostics has entered into a project with SAP AG (NYSE: SAP) to use the SAP HANA® platform to enable Alacris’ proprietary ModCell™ system. Using SAP HANA is expected to accelerate the modelling and prediction of drug action by Alacris’ ModCellTM system by a factor of several thousand. This allows […]

Read More